Sarah Willis MPH, PhD

Sarah Willis is currently a Director within Pfizer’s Evidence Generation Platform team where she focuses on real-world evidence studies for vaccines, including pneumococcal, meningococcal, and tickborne disease vaccines. Prior to joining Pfizer in 2022, Sarah spent over 10 years enhancing public health surveillance in conjunction with state and local health departments.

Most recently, she worked with Harvard Medical School and the Massachusetts Department of Public Health to implement a surveillance platform that identifies and reports notifiable diseases from electronic health record systems to the state’s surveillance system. She also received a PhD in Epidemiology from the University of North Carolina, Chapel Hill, and a Masters of Public Health from the State University of New York at Albany.